Image-Guided Radiation Therapy Market By Product, By Procedure (IMRT, Stereotactic Therapy, Particle Therapy, Others) By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

Image-guided Radiation Therapy Market

The image-guided radiation therapy market was valued at $1.9 billion in 2023 and is projected to reach $3.3 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.

Image-guided radiation therapy is a frequent imaging process used in the treatment of cancer. The therapy involves several imaging techniques such as MRI, PET, and CT scans, which allow for precise targeting of radiation for killing the cancer cells. The precise targeting is performed using the high-quality images generated by imaging technologies. This approach elevates the accuracy of treatment, improves therapy outcomes, and reduces radiation-related complications, making image-guided radiation therapy a necessary procedure in modern oncology practice.

Increase in prevalence of diverse forms of cancers and rise in demand for targeted cancer treatment are the major drivers of the image-guided radiation therapy market. In addition, the deployment of real-time imaging during ongoing treatment sessions has boosted the efficacy of treatment, thereby boosting the demand for image-guided radiation therapy. Surface-guided radiation therapy has recently witnessed widespread adoption in several oncology facilities due to its cutting-edge attributes such as intra-fraction motion monitoring and respiratory gating.

However, the cost associated with procuring instruments related to image-guided radiation therapy, along with the high costs of treatment for the patients, is a major restraint for the market. On the contrary, enhancements in technology are diversifying the prospects of the therapy and refining the healing process. Assimilation of AI and ML is enabling the delivery of personalized cancer treatment according to the vitals and requirements of the patient. For instance, in the case of a patient suffering from glioblastoma, an AI-based dose optimization software was used to tailor the radiation therapy. This included the delivery of optimal dose of radiation, resulting in maximum tumor control while guarding the pivotal parts of the brain such as brainstem and optic nerves.

Segment Review

The image-guided radiation therapy market is segmented into product, procedure, end user, and region. On the basis of product, the market is divided into 4D RT, LINAC, MRI-guided radiotherapy, portal imaging, and CT scanning. By procedure, it is classified into IMRT (intensity modulation radiation therapy), stereotactic therapy, particle therapy, and others. Depending on end user, it is categorized into hospitals, independent radiotherapy centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the LINAC segment dominates the market.

By procedure, the IMRT (intensity modulation radiation therapy) segment is the leader in the market.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global image-guided radiation therapy market include Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, ViewRay, Inc., Siemens Healthineers AG, Hitachi, Ltd, Brainlab AG, MEVION MEDICAL SYSTEMS, INC., C-Rad AB, Sumitomo Heavy Industries, Ltd., and Philips Healthcare. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Additional company profiles with specific to client's interest

Key Market Segments

By Product

4D RT
LINAC
MRI-guided Radiotherapy
Portal Imaging
CT Scanning

By Procedure

IMRT (intensity modulation radiation therapy)
Stereotactic Therapy
Particle Therapy
Others

By End User

Hospitals
Independent Radiotherapy Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

Key Market Players:

Varian Medical Systems, Inc.
Elekta AB, Accuray Incorporated
ViewRay, Inc.
Siemens Healthineers AG
Hitachi, Ltd
Brainlab AG
MEVION MEDICAL SYSTEMS, INC.
C-Rad AB
Sumitomo Heavy Industries, Ltd.
Philips Healthcare

Product Code: A323701

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.5. Market Dynamics
- 3.5.1. Drivers
- 3.5.2. Restraints
- 3.5.3. Opportunities

CHAPTER 4: IMAGE-GUIDED RADIATION THERAPY MARKET, BY PRODUCT

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
4.2. 4D RT
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. LINAC
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
4.4. MRI-guided Radiotherapy
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
4.5. Portal Imaging
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
4.6. CT Scanning
- 4.6.1. Key Market Trends, Growth Factors and Opportunities
- 4.6.2. Market Size and Forecast, By Region
- 4.6.3. Market Share Analysis, By Country

CHAPTER 5: IMAGE-GUIDED RADIATION THERAPY MARKET, BY PROCEDURE

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Procedure
5.2. IMRT (intensity Modulation Radiation Therapy)
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Stereotactic Therapy
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
5.4. Particle Therapy
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
5.5. Others
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country

CHAPTER 6: IMAGE-GUIDED RADIATION THERAPY MARKET, BY END USER

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Independent Radiotherapy Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country

CHAPTER 7: IMAGE-GUIDED RADIATION THERAPY MARKET, BY REGION

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Product
- 7.2.3. Market Size and Forecast, By Procedure
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Image-Guided Radiation Therapy Market
  - 7.2.6.1. Market Size and Forecast, By Product
  - 7.2.6.2. Market Size and Forecast, By Procedure
  - 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Image-Guided Radiation Therapy Market
  - 7.2.7.1. Market Size and Forecast, By Product
  - 7.2.7.2. Market Size and Forecast, By Procedure
  - 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Image-Guided Radiation Therapy Market
  - 7.2.8.1. Market Size and Forecast, By Product
  - 7.2.8.2. Market Size and Forecast, By Procedure
  - 7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Product
- 7.3.3. Market Size and Forecast, By Procedure
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Image-Guided Radiation Therapy Market
  - 7.3.6.1. Market Size and Forecast, By Product
  - 7.3.6.2. Market Size and Forecast, By Procedure
  - 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany Image-Guided Radiation Therapy Market
  - 7.3.7.1. Market Size and Forecast, By Product
  - 7.3.7.2. Market Size and Forecast, By Procedure
  - 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy Image-Guided Radiation Therapy Market
  - 7.3.8.1. Market Size and Forecast, By Product
  - 7.3.8.2. Market Size and Forecast, By Procedure
  - 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain Image-Guided Radiation Therapy Market
  - 7.3.9.1. Market Size and Forecast, By Product
  - 7.3.9.2. Market Size and Forecast, By Procedure
  - 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK Image-Guided Radiation Therapy Market
  - 7.3.10.1. Market Size and Forecast, By Product
  - 7.3.10.2. Market Size and Forecast, By Procedure
  - 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest of Europe Image-Guided Radiation Therapy Market
  - 7.3.11.1. Market Size and Forecast, By Product
  - 7.3.11.2. Market Size and Forecast, By Procedure
  - 7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Product
- 7.4.3. Market Size and Forecast, By Procedure
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Image-Guided Radiation Therapy Market
  - 7.4.6.1. Market Size and Forecast, By Product
  - 7.4.6.2. Market Size and Forecast, By Procedure
  - 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan Image-Guided Radiation Therapy Market
  - 7.4.7.1. Market Size and Forecast, By Product
  - 7.4.7.2. Market Size and Forecast, By Procedure
  - 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Image-Guided Radiation Therapy Market
  - 7.4.8.1. Market Size and Forecast, By Product
  - 7.4.8.2. Market Size and Forecast, By Procedure
  - 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea Image-Guided Radiation Therapy Market
  - 7.4.9.1. Market Size and Forecast, By Product
  - 7.4.9.2. Market Size and Forecast, By Procedure
  - 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia Image-Guided Radiation Therapy Market
  - 7.4.10.1. Market Size and Forecast, By Product
  - 7.4.10.2. Market Size and Forecast, By Procedure
  - 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Image-Guided Radiation Therapy Market
  - 7.4.11.1. Market Size and Forecast, By Product
  - 7.4.11.2. Market Size and Forecast, By Procedure
  - 7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Product
- 7.5.3. Market Size and Forecast, By Procedure
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Image-Guided Radiation Therapy Market
  - 7.5.6.1. Market Size and Forecast, By Product
  - 7.5.6.2. Market Size and Forecast, By Procedure
  - 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa Image-Guided Radiation Therapy Market
  - 7.5.7.1. Market Size and Forecast, By Product
  - 7.5.7.2. Market Size and Forecast, By Procedure
  - 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Image-Guided Radiation Therapy Market
  - 7.5.8.1. Market Size and Forecast, By Product
  - 7.5.8.2. Market Size and Forecast, By Procedure
  - 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Image-Guided Radiation Therapy Market
  - 7.5.9.1. Market Size and Forecast, By Product
  - 7.5.9.2. Market Size and Forecast, By Procedure
  - 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

9.1. Varian Medical Systems, Inc.
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
9.2. Elekta AB, Accuray Incorporated
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
9.3. ViewRay, Inc.
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
9.4. Siemens Healthineers AG
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
9.5. Hitachi, Ltd
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
9.6. Brainlab AG
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
9.7. MEVION MEDICAL SYSTEMS, INC.
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
9.8. C-Rad AB
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
9.9. Sumitomo Heavy Industries, Ltd.
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
9.10. Philips Healthcare
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments